Biointron Biological Inc.

Biointron Biological Inc. is an active contract research organization founded in 2012 that specializes in high-throughput antibody discovery, expression, and optimization services for global biotech and pharmaceutical companies. The company has delivered tens of thousands of recombinant antibodies to over two thousand clients worldwide. Its offerings include rapid gene-to-antibody workflows (~two weeks), bispecific antibody production, VHH/nanobody discovery with unique binders guaranteed via its own alpaca breeding base, hybridoma sequencing with high accuracy guarantees, humanization/affinity maturation services, and commercial sublicensing of the CHOK1BN cell line for clinical manufacturing. The company operates at commercial scale with over 400 employees and more than 14,600 m² production area.